Aktuell 11 Apr 2024 Circunis wird von Seedling Foundation gefördert Circunis hat die Finanzierung für den Aufbau eines Online-Marktplatzes gesichert, über den überschüssige Lebensmittel und Nebenströme gehandelt w...
News 11 Apr 2024 Circunis obtains funding from the Seedling Foundation Circunis has secured financing to establish an online marketplace that can be used to trade surplus food and by-products. Following in the footst...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 Apr 2024 10:15–12:10 Zürich Svizzera
Evento S-GE Fattori chiave di successo per fare affari in Giappone 23 Apr 2024 10:15–12:10 Zürich Svizzera
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23 Apr 2024 10:15–12:10 Zürich Svizzera
Innovation 12 Mar 2024 The Valley joins forces with S-GE to showcase Switzerland as a global hub for food and nutrition innovation Swiss Food & Nutrition Valley (SFNV), a network of more than 140 Swiss food innovators, has signed a strategic partnership with Switzerland G...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 Lug 2024–28 Lug 2024 Nangang District Taiwan
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 Lug 2024–28 Lug 2024 Nangang District Taiwan
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 22 Mag 2024 CUTISS secures 25 million Swiss francs from investors CUTISS has closed a first Series C financing round in the amount of 25 million Swiss francs. With this, the life sciences company with a focus on...
SWISS Pavilion SWISS BIOTECH Pavilion @ BIO-Asia Taiwan 2024 24 Lug 2024–28 Lug 2024 Nangang District Taiwan
Actualités 17 Apr 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News 21 Mag 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News 27 Mag 2024 Securecell and DataHow collaborating with British partner for cell research Securecell and DataHow are working together as part of a British-Swiss project to promote innovation in relation to the development of cell and g...